InvestorsHub Logo
Post# of 253146
Next 10
Followers 840
Posts 120458
Boards Moderated 18
Alias Born 09/05/2002

Re: mcbio post# 209197

Monday, 06/26/2017 9:00:45 AM

Monday, June 26, 2017 9:00:45 AM

Post# of 253146
ENTA reports preclinical data on EDP-938 RSV inhibitor; phase-1 to begin 4Q17:

http://ir.enanta.com/news-releases/news-release-details/enanta-announces-new-data-edp-938-novel-non-fusion-inhibitor

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.